-
Active Trials
-
Phase 3
-
Phase 2
-
Phase 1
-
Results Pending
📊
Pipeline Summary
Expected Approvals
FDA Decisions 2 upcoming PDUFA dates
Oveporexton (TAK-861) Narcolepsy type 1 (excessive daytime sleepiness) NDA
Rusfertide Polycythemia vera (PV) NDA
Clinical Trials
Loading...